InDex’s advisory boards support the strong InDex team, ensure clinical relevance of InDex’s studies, support increased awareness and enable outreach to achieve broad patient recruitment. Many leading experts are also involved in the development of the trial design and will be involved in implementation of the phase III program.

Brian G. Feagan, Prof., MD

London Health Sciences Centre, Western University, London, Ontario, Canada


Christina Ha, Ass. Prof., MD

Mayo Clinic, Scottsdale, Arizona, USA


Florian Rieder, MD

Cleveland Clinic, Cleveland, Ohio, USA


David T. Rubin, Prof., MD

University of Chicago, Chicago, Illinois, USA


Bruce E. Sands, Prof., MD

The Mount Sinai Hospital, New York, New York, USA